News
age related macular degeneration
Experimental light-activated eye drops show promising results
The drugs work by taking over the job that the photoreceptors perform and can be administered either by injection or by eye drops.
dry amd
Lutein supplements may benefit early AMD patients
Nine randomized, placebo-controlled trials were evaluated by researchers.
age-related macular degeneration
Dry AMD patients may benefit from light therary
The double-masked, prospective randomized trial included 100 adults with dry AMD and evaluated whether a targeted light therapy could improve the vision in the participants.
age-related macular degeneration
Diabetic drug associated with lower risk of progression of age-related macular degeneration
Drug commonly used to treat diabetes may lower risk of progression of age-related macular degeneration.
age-related macular degeneration
Stem cell retinal implant enters phase 2b testing
Researchers at the Roski Eye Institute are testing a stem cell retinal implant as a possible treatment for advanced dry age-related macular degeneration.